COMMUNIQUÉS West-GlobeNewswire

Certara to Participate in Upcoming Investor Conferences
21/08/2024
RADNOR, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the following investor [...]
Globus Medical Launches ADIRA™ XLIF™ Plate System
21/08/2024
AUDUBON, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced the commercial launch of the ADIRA™ XLIF™ Plate System, the Company’s first [...]
Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment
21/08/2024
Vancouver, Canada, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]
LifeStance to Present at the 22nd Annual Morgan Stanley Healthcare Conference
21/08/2024
SCOTTSDALE, Ariz., Aug. 21, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation’s largest providers of outpatient mental health care, today announced that management will present at [...]
Guardion Health Sciences Declares Cash Dividend of $5.00 Per Share of Common Stock
21/08/2024
HOUSTON, TEXAS, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) today announced that its Board of Directors declared a cash dividend in an amount equal to $5 [...]
Inari Medical to Present at Upcoming Investor Conferences
21/08/2024
IRVINE, Calif., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]
Clover Health to Participate in Upcoming 2024 Wells Fargo Healthcare Conference
21/08/2024
FRANKLIN, Tenn., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to [...]
Inspire Medical Systems, Inc. to Present at Upcoming Investor Conferences
21/08/2024
MINNEAPOLIS, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]
SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX®
21/08/2024
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, today announced a new contract with the U.S. [...]
MDxHealth Reports Q2 and Half Year 2024 Results
21/08/2024
MDxHealth Reports Q2 and Half Year 2024 Results Year-over-year Q2 revenues increase by 32% to $22.2 million Year-over-year H1 revenues increase by 34% to 42.0 million Conference call with Q&A today at 4:30 PM ET / [...]
Le KFSHRC présente ses innovations en matière d’éducation médicale à l’occasion de la conférence AMEE 2024, organisée en Suisse
21/08/2024
RIYAD, Arabie saoudite, 21 août 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSHRC) poursuit l’expansion de son empreinte mondiale en participant à l’édition 2024 de la conférence [...]
ProLynx announces preclinical results of long-acting semaglutide requiring once monthly dosing
21/08/2024
SAN FRANCISCO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- ProLynx Inc. today announced the use of their technology to create a long-acting semaglutide that can be administered once monthly. The ProLynx technology involves [...]
Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country
21/08/2024
The order was anticipated as part of the 2024 guidance and has no impact on the remaining 2024/25 capacity for the Company’s smallpox and mpox vaccine. COPENHAGEN, Denmark, August 21, 2024 – Bavarian Nordic A/S (OMX: [...]
Orion Corporation: Managers’ transactions – Niclas Lindstedt
21/08/2024
ORION CORPORATION MANAGERS’ TRANSACTIONS 21 AUGUST 2024 at 18.45 EEST Orion Corporation: Managers’ transactions – Niclas Lindstedt Orion Corporation has received the following disclosure under Market Abuse Regulation ( [...]
AiM Medical Robotics Announces Co-Founder Dr. Julie Pilitsis Elected as President of the American Society for Stereotactic and Functional Neurosurgery
21/08/2024
— New role underscores Dr. Pilitsis’s leadership in advancing neurosurgical techniques and precision-guided robotics — WORCESTER, Mass., Aug. 21, 2024 (GLOBE NEWSWIRE) -- AiM Medical Robotics Inc. (AiM), a leading [...]
Kymera Therapeutics Announces Closing of Upsized $225 Million Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
21/08/2024
WATERTOWN, Mass., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein [...]
New Report Reveals Growing Adoption of Virtual Reality in Senior Care
21/08/2024
Rendever’s in-depth analysis provides fresh data and insights on the technology’s impact and future directions BOSTON, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Rendever , the Boston-based company leading the industry in [...]
PharmaTher’s Sairiyo Therapeutics Announces Independent Screening Identifying Cepharanthine’s Potential to Bind to Monkeypox (Mpox) Proteins
21/08/2024
TORONTO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, announces that Sairiyo Therapeutics Inc. (“Sairiyo”), a [...]
BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.
21/08/2024
GRANTS, NEW MEXICO, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”) today announced that it has signed a letter of intent to supply its DEA-approved marijuana [...]

Pages